The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determination of the recommended phase II dose of birinapant in combination with pembrolizumab: Results from the dose-escalation phase of BPT-201.
 
Russell J. Schilder
Consulting or Advisory Role - Celsion; Flatiron Health; Immunogen; Incyte
 
Mark Albertella
Employment - Medivir
Stock and Other Ownership Interests - Medivir
Patents, Royalties, Other Intellectual Property - Medivir
 
James Fredric Strauss
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck
Consulting or Advisory Role - Tempus
Other Relationship - Dialectic Therapeutics
 
Malin Sydvander
Employment - Medivir
 
Dung T. Le
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".
 
Stefan Norin
Employment - Medivir
Stock and Other Ownership Interests - Iconovo
 
Monica M. Mita
Research Funding - Seagen (Inst)
 
Emma Boström
Employment - Medivir
Stock and Other Ownership Interests - Medivir
 
Siqing Fu
Research Funding - Anaeropharma (Inst); Aprea Therapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Endocyte (Inst); Huya Bioscience International (Inst); Lilly (Inst); MacroGenics (Inst); Medivir (Inst); NeuPharma, Inc. (Inst); Novartis (Inst); OncoMed (Inst); Parexel International, LLC (Inst); Takeda (Inst)
 
Linda Basse
Employment - Medivir
 
Richard Bethell
Employment - Medivir
Leadership - Medivir
Stock and Other Ownership Interests - GlaxoSmithKline; Medivir
Patents, Royalties, Other Intellectual Property - Medivir